Kymera Therapeutics

Kymera Therapeutics Announces Key Leadership Appointments

WATERTOWN, Mass., Dec. 16, 2020 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company advancing targeted protein degradation to deliver novel, small molecule protein degrader therapeutics, today announced the appointments of William Leong, PhD, as Vice President